Viewing StudyNCT06283589



Ignite Creation Date: 2024-05-06 @ 8:10 PM
Last Modification Date: 2024-10-26 @ 3:22 PM
Study NCT ID: NCT06283589
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-05-01
First Post: 2024-02-21

Brief Title: The SEAPORT 1 Study Evaluation of the Safety and Tolerability of INZ-701 in Adults With End-Stage Kidney Disease Undergoing Hemodialysis
Sponsor: Inozyme Pharma
Organization: Inozyme Pharma

Conditions & Keywords Data

Conditions:
Name
Calciphylaxis
Keywords:
Name View
calcinosis View
calcific uremic arteriolopathy View
calcinosis cutis View
calcification View
calcium metabolism disorders View
mineral bone disorder MBD View
fusion protein View
vascular calcificiation View
end stage renal disease ESKD View
chronic kidney disease CKD View